Scribe Therapeutics, Inc. (SCTX)
Scribe Therapeutics Market Cap : 531.03M for Sept. 21, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| September 18, 2026 | 624.75M |
| September 17, 2026 | 608.46M |
| September 16, 2026 | 550.91M |
| September 15, 2026 | 599.38M |
| September 14, 2026 | 556.97M |
| September 11, 2026 | 563.03M |
| September 10, 2026 | 557.92M |
| September 09, 2026 | 556.78M |
| September 08, 2026 | 593.32M |
| September 04, 2026 | 542.77M |
| September 03, 2026 | 583.29M |
| September 02, 2026 | 584.99M |
| September 01, 2026 | 549.02M |
| August 31, 2026 | 578.17M |
| August 28, 2026 | 538.42M |
| August 27, 2026 | 506.93M |
| August 26, 2026 | 557.20M |
| August 25, 2026 | 548.50M |
| August 24, 2026 | 654.76M |
| August 21, 2026 | 599.92M |
| August 20, 2026 | 577.07M |
| Date | Value |
|---|---|
| August 19, 2026 | 545.78M |
| August 18, 2026 | 476.52M |
| August 17, 2026 | 372.47M |
| August 14, 2026 | 364.38M |
| August 13, 2026 | 358.05M |
| August 12, 2026 | 404.46M |
| August 11, 2026 | 412.01M |
| August 10, 2026 | 438.20M |
| August 07, 2026 | 457.01M |
| August 06, 2026 | 446.64M |
| August 05, 2026 | 418.34M |
| August 04, 2026 | 387.76M |
| August 03, 2026 | 366.23M |
| July 31, 2026 | 342.41M |
| July 30, 2026 | 358.58M |
| July 29, 2026 | 322.72M |
| July 28, 2026 | 317.45M |
| July 27, 2026 | 333.44M |
| July 24, 2026 | 380.55M |
| July 23, 2026 | 263.66M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Ionis Pharmaceuticals, Inc. | 7.434B |
| Cypherpunk Technologies, Inc. | 365.32M |
| ACADIA Pharmaceuticals, Inc. | 4.543B |
| Alnylam Pharmaceuticals, Inc. | 32.66B |
| Anika Therapeutics, Inc. | 277.30M |
Market Cap Related Metrics
| PS Ratio | 19.56 |
| Price | 28.05 |
| Earnings Yield | -7.30% |